Highland Associates’s Gilead Sciences GILD Stock Holding History

Highland Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$41.7M	Buy	+617,000	New	+$40.6M	5.96%	3

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Highland Associates's GILD Position: Q2 2019 in Review

Highland Associates opened a new position in Gilead Sciences (GILD) in Q2 2019: 617,000 shares worth $41.7M. The stake represents 5.96% of the portfolio and ranks #3 among its holdings.

1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

Highland Associates held 617,000 shares of Gilead Sciences worth $41.7M as of Q2 2019.
Gilead Sciences was a new Highland Associates position in Q2 2019.
Gilead Sciences made up 5.96% of Highland Associates's portfolio in Q2 2019, its #3 holding.
1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Highland Associates's 13F filing for Q2 2019, filed 8 Aug 2019.